0001728411-22-000004.txt : 20220824
0001728411-22-000004.hdr.sgml : 20220824
20220823175958
ACCESSION NUMBER: 0001728411-22-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220824
DATE AS OF CHANGE: 20220823
EFFECTIVENESS DATE: 20220824
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: DMC Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001728411
IRS NUMBER: 471479674
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-456800
FILM NUMBER: 221188479
BUSINESS ADDRESS:
STREET 1: 2477 55TH STREET, SUITE 120
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-239-7239
MAIL ADDRESS:
STREET 1: 2477 55TH STREET, SUITE 120
CITY: BOULDER
STATE: CO
ZIP: 80301
D
1
primary_doc.xml
X0708
D
LIVE
0001728411
DMC Biotechnologies, Inc.
2477 55TH STREET, SUITE 120
BOULDER
CO
COLORADO
80301
720-239-7239
DELAWARE
None
None
Corporation
true
Matthew
Lipscomb
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Executive Officer
Director
Michael
D.
Lynch
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Carolyn
Fritz
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Rob
van der Meij
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Josko
Bobanovic
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Doug
Cameron
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Alastair
Cooper
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Ashley
Jenkins
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2022-08-11
false
true
true
false
0
66720
66720
0
The Total Offering Amount and Total Amount Sold represent the aggregate exercise price of a warrant to purchase shares of capital stock of the Issuer.
false
1
0
0
0
false
DMC Biotechnologies, Inc.
/s/ Matthew Lipscomb
Matthew Lipscomb
Chief Executive Officer
2022-08-19